June 18, 2008
etrials Worldwide, Inc. will launch its new corporate branding and product re-positioning at this year’s Drug Information Association (DIA) Annual Meeting, June 22-26, 2008, in Boston, Mass. The company’s new branding and product positioning, backed by extensive market research, more accurately communicates etrials’ integrated solution capabilities, which are now better aligned to address customer pain points and meet changing customer requirements.
“The market is starting to understand that in order to realize the full benefit of eClinical technology, disparate data capture environments must be integrated and synchronized,” said Chip Jennings, president and CEO of etrials. “Many of our customers chose etrials because they realized purchasing separate technologies utilized in silos provided only marginal value to a successful study endpoint. Our integrated solutions capabilities, which translate into higher quality data, actionable information, and faster, more informed decision-making, are the cornerstone of our new branding and positioning.
“We also are excited to be introducing some of our new tools and automation at this year’s DIA Annual Meeting, and look forward to illustrating how our solutions align with customers’ needs,” added Jennings. “These tools are another step forward in a series of strategic initiatives designed to enhance service delivery and build scale in our operations.”
The company’s new look and positioning can be found immediately at www.etrials.com, with the official kick-off at the etrials Booth #244 at the DIA Annual Meeting in Boston on Sunday.